May 31, 2011, 12.26 PM IST
Surya Pharma Mar '11 sales at Rs 450.26 crore
Surya Pharmaceutical has reported a sales turnover of Rs 450.26 crore and a net profit of Rs 27.79 crore for the quarter ended Mar '11
Like this story, share it with millions of investors on M3
Surya Pharma Mar '11 sales at Rs 450.26 crore
Surya Pharmaceutical has reported a sales turnover of Rs 450.26 crore and a net profit of Rs 27.79 crore for the quarter ended Mar '11
Like this story, share it with millions of investors on M3
Surya Pharma Mar '11 sales at Rs 450.26 crore
Surya Pharmaceutical has reported a sales turnover of Rs 450.26 crore and a net profit of Rs 27.79 crore for the quarter ended Mar '11
Share . Email . Print . A+A-
Surya Pharmaceutical has reported a sales turnover of Rs 450.26 crore and a net profit of Rs 27.79 crore for the quarter ended Mar '11.
| For the quarter ended Mar 2010 the sales turnover was Rs 351.29 crore and net profit was Rs 20.98 crore.
|
| | | Quarterly Results of Surya Pharmaceutical | -------- in Rs. Cr. -------- |
| | Mar '10 | | | Dec '10 | Mar '11 | | Sales Turnover | 351.29 | | | 398.09 | 450.26 | | Other Income | 4.50 | | | 1.40 | -- | | Total Income | 355.79 | | | 399.49 | 450.26 | | Total Expenses | 308.20 | | | 331.38 | 379.03 | | Operating Profit | 43.09 | | | 66.71 | 71.23 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 47.59 | | | 68.11 | 71.23 | | Interest | 17.27 | | | 25.36 | 32.82 | | PBDT | 30.31 | | | 42.74 | 38.43 | | Depreciation | 5.03 | | | 7.75 | 3.72 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 25.28 | | | 34.99 | 34.71 | | Tax | 4.30 | | | 6.97 | 6.92 | | Net Profit | 20.98 | | | 28.02 | 27.79 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 14.50 | | | 1.53 | 1.44 | | Book Value | -- | | | -- | -- | | Equity | 14.47 | | | 18.33 | 19.28 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 1.00 | 1.00 | | Source : Religare Technova |
|
|
From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'
The latest earning numbers FIRST on CNBC-TV18
|
